Transcriptomics Technologies Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The transcriptomic technologies market was estimated to be worth USD 7.4
billion globally in 2024 and is anticipated to expand at a compound annual
growth rate (CAGR) of 6.2% over the course of the forecast period. The study of
the transcriptome, or the entire collection of RNA transcripts generated by the
genome in a given cell or under particular conditions, is known as
transcriptomics.
It is propelled by advances in precision medicine, drug development, and RNA
sequencing. Advances in RNA sequencing, especially single-cell and next-generation
RNA sequencing, have greatly improved the capacity to more accurately examine
gene expression. The need for sophisticated gene expression analysis has
increased due to the rise in hereditary abnormalities and chronic diseases like
diabetes, cancer, and cardiovascular ailments.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/transcriptomics-technologies-market
Growth
Drivers
The industry is
expanding at a substantial rate thanks to rising investments in genetic
research. The demand in this field is increasing as a result of government
funding and initiatives for genomic research, as well as strategic alliances
between biopharmaceutical companies, research institutions, and technology
providers. These alliances are encouraging cooperative efforts that expedite
the research and development process. Research efforts have been strengthened
by the growing emphasis on comprehending disease mechanisms at the
transcriptome level, which has attracted both governmental and private support.
pharmacological
development frequently uses transcriptomics technologies to determine
pharmacological targets, comprehend mechanisms of action, and evaluate the
effectiveness of medications. Collaborations between academic institutions and
business titans are greatly supporting market expansion. Single-cell RNA
sequencing is anticipated to spur investment and innovation in the global transcriptomics market due to technical advancements.
Segmentation
By Type
· Consumables
· Instruments
· Software
· Services
By
Technologies
· Micro
Array
· q
PCR
· Sequencing
Technology
By
Application
· Drug
Discovery
· Diagnostics
and Disease Profiling
· Others
By Region
· Asia
Pacific
· North
America
· Latin
America
· Middle
East and Africa
· Europe
Key
Players
· Danaher
Corp.
· Affymetrix
Inc.
· Bio-Rad
Laboratories, Inc.
· Promega
Corporation
· Merck
and Company Inc.
· Fluidigm
Corporation
· LC
Sciences
· F.
Hoffmann-La Roche Ltd.
· Life
Technologies Corporation
· Illumina
· Thermo
Fisher Scientific
· Agilent
Technologies
· Qiagen
N.V.
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/transcriptomics-technologies-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment